Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 4NIH 4INDUSTRY 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 73Tumor-Agnostic 6Gastrointestinal 6CNS 5Head & Neck 3Genitourinary 3Thoracic 2Gynecologic 2Other solid neoplasm 1

Conditions

Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 166Cisplatin 112Cetuximab 76Nivolumab 52Carboplatin 51Fluorouracil 48Paclitaxel 42Docetaxel 37Gemcitabine 30Radiotherapy 28Capecitabine 19Cyclophosphamide 18durvalumab 17Injections 17lenvatinib 16atezolizumab 16cemiplimab 15spartalizumab 13fludarabine 13avelumab 12Ipilimumab 12Pemetrexed 11130-nm albumin-bound paclitaxel 11Oxaliplatin 10Gefitinib 10tremelimumab 9Drug Therapy 9tislelizumab 8epacadostat 8budigalimab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Lapatinib × Head & Neck × Clear all
NCT00387127 2015-06-25

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

GlaxoSmithKline

Phase 2 Completed
67 enrolled 18 charts
Head & Neck

Head and Neck Neoplasms

NCT00424255 2014-07-18

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

GlaxoSmithKline

Phase 3 Completed
688 enrolled 19 charts
Head & Neck

Head and Neck Neoplasms

NCT00371566 2010-04-06

A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

GlaxoSmithKline

Phase 2 Completed
107 enrolled 34 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡